126
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Interleukin-12B gene polymorphisms and bronchial asthma risk: A meta-analysis

, MD, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 777-783 | Received 16 May 2016, Accepted 26 Dec 2016, Published online: 07 Apr 2017

References

  • Kudo M, Ishigatsubo Y, Aoki I. Pathology of asthma. Front Microbiol 2013;4:263.
  • Harb H, Renz H. Update on epigenetics in allergic disease. J Allergy Clin Immunol 2015;135:15–24.
  • Lajunen TK, Jaakkola JJ, Jaakkola MS. Interleukin 6 SNP rs1800797 associates with the risk of adult-onset asthma. Genes Immun 2016;17:193–198.
  • Pan Y, Li S, Xie X, Li M. Association between thromboxane A2 receptor polymorphisms and asthma risk: a meta-analysis. J Asthma 2016;53:576–582.
  • Wang Y, Hu H, Wu J, Zhao X, Zhen Y, Wang S, et al. The IL6R gene polymorphisms are associated with sIL-6R, IgE and lung function in Chinese patients with asthma. Gene 2016;585:51–57.
  • Miteva L, Stanilova S. The combined effect of interleukin (IL)-10 and IL-12 polymorphisms on induced cytokine production. Hum Immunol 2008;69:562–566.
  • Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 2010;125:S53–S72.
  • Falcai A, Soeiro-Pereira PV, Kubo CA, Aranda CS, Sole D, Condino-Neto A. Peripheral blood mononuclear cells from severe asthmatic children release lower amounts of IL-12 and IL-4 after LPS stimulation. Allergol Immunopathol (Madr) 2015;43:482–486.
  • Zoratti E, Havstad S, Wegienka G, Nicholas C, Bobbitt KR, Woodcroft KJ, et al. Differentiating asthma phenotypes in young adults through polyclonal cytokine profiles. Ann Allergy Asthma Immunol 2014;113:25–30.
  • Yokouchi Y, Nukaga Y, Shibasaki M, Noguchi E, Kimura K, Ito S, et al. Significant evidence for linkage of mite-sensitive childhood asthma to chromosome 5q31–q33 near the interleukin 12 B locus by a genome-wide search in Japanese families. Genomics 2000;66:152–160.
  • Xu Z, Pei L, Zhang F, Hu X, Gui Y, Wang L, et al. A functional variant in IL12B promoter modulates its expression and associates with increased risk of allergic asthma. Genes Immun 2013;14:238–243.
  • Walley AJ, Wiltshire S, Ellis CM, Cookson WO. Linkage and allelic association of chromosome 5 cytokine cluster genetic markers with atopy and asthma associated traits. Genomics 2001;72:15–20.
  • Padron-Morales J, Sanz C, Davila I, Munoz-Bellido F, Lorente F, Isidoro-Garcia M. Polymorphisms of the IL12B, IL1B, and TNFA genes and susceptibility to asthma. J Investig Allergol Clin Immunol 2013;23:487–494.
  • Chen T, Liang W, Gao L, Wang Y, Liu Y, Zhang L, et al. Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population. Hum Immunol 2011;72:603–606.
  • Movahedi M, Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA. IL-10, TGF-beta, IL-2, IL-12, and IFN-gamma cytokine gene polymorphisms in asthma. J Asthma 2008;45:790–794.
  • Trajkov D, Mirkovska-Stojkovikj J, Arsov T, Petlichkovski A, Strezova A, Efinska-Mladenovska O, et al. Association of cytokine gene polymorphisms with bronchial asthma in Macedonians. Iran J Allergy Asthma Immunol 2008;7:143–156.
  • Hirota T, Suzuki Y, Hasegawa K, Obara K, Matsuda A, Akahoshi M, et al. Functional haplotypes of IL-12B are associated with childhood atopic asthma. J Allergy Clin Immunol 2005;116:789–795.
  • Morahan G, Huang D, Wu M, Holt BJ, White GP, Kendall GE, et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 2002;360:455–459.
  • Khoo SK, Hayden CM, Roberts M, Horak E, de Klerk N, Zhang G, et al. Associations of the IL12B promoter polymorphism in longitudinal data from asthmatic patients 7 to 42 years of age. J Allergy Clin Immunol 2004;113:475–481.
  • Tug E, Ozbey U, Tug T, Yuce H. Relationship between the IL-12B promoter polymorphism and allergic rhinitis, familial asthma, serum total IgE, and eosinophil level in asthma patients. J Investig Allergol Clin Immunol 2009;19:21–26.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336–341.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603–605.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–1558.
  • Shi Q, Pavey ES, Carter RE. Bonferroni-based correction factor for multiple, correlated endpoints. Pharm Stat 2012;11:300–309.
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088–1101.
  • Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629–634.
  • Trinchieri G, Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol Today 1994;15:460–463.
  • Yaghini N, Mahmoodi M, Hassanshahi G, Asadikaram G, Arababadi MK, Rezaeian M, et al. Genetic variation of IL-12B (+1188 region) is associated with its decreased circulating levels and susceptibility to Type 2 diabetes. Biomark Med 2012;6:89–95.
  • Lewkowich IP, Lajoie S, Stoffers SL, Suzuki Y, Richgels PK, Dienger K, et al. PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production. Mucosal Immunol 2013;6:728–739.
  • Naseer T, Minshall EM, Leung DY, Laberge S, Ernst P, Martin RJ, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997;155:845–851.
  • Hasko G, Szabo C. IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. Br J Pharmacol 1999;127:1295–1304.
  • Kim YS, Choi SJ, Choi JP, Jeon SG, Oh S, Lee BJ, et al. IL-12-STAT4-IFN-gamma axis is a key downstream pathway in the development of IL-13-mediated asthma phenotypes in a Th2 type asthma model. Exp Mol Med 2010;42:533–546.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.